Supriya K. Saha - Concepedia

Author

Supriya K. Saha

Massachusetts General Hospital ORCID

Also Known As

S Saha, S. Saha, SUPRIYA SAHA, Supriya K Saha, Supriya K. Saha, Supriya Kumar Saha, Supriya Saha

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University University of California, Los Angeles Dana-Farber Cancer Institute Broad Institute

About

Supriya K. Saha is an author at Massachusetts General Hospital specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.4K
2	Cell Biology	6	6	1.9K
3	Natural Sciences	1	1	38
4	Allergy	1	1	33
5	Biostatistics	1	1	109

Supriya K. Saha

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response Gagik Oganesyan, Supriya K. Saha, Beichu Guo, Nature InflammationToll-like ReceptorsHost ResponseToll-like Receptor-dependentCritical Role	2005	857
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise Supriya K. Saha, Andrew X. Zhu, Charles S. Fuchs, The Oncologist	2016	776
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma Lipika Goyal, Supriya K. Saha, Leah Y. Liu, Cancer Discovery	2016	527
Type I Interferon Production Enhances Susceptibility to <i>Listeria monocytogenes</i> Infection Ryan M. O’Connell, Supriya K. Saha, Sagar A. Vaidya, The Journal of Experimental Medicine	2004	484
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer Supriya K. Saha, Christine A. Parachoniak, Krishna S. Ghanta, Nature Tumor BiologyPromote Biliary CancerHepatologyBiliary CancerLiver Physiology	2014	455
Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif Supriya K. Saha, Eric M. Pietras, Jeannie Q. He, The EMBO Journal Signal TransductionSpecific InteractionImmunologyAntiviral Drug DevelopmentAntiviral Therapy	2006	413
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma Lipika Goyal, Lei Shi, Leah Y. Liu, Cancer Discovery	2019	363
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b Sita Kugel, Carlos Sebastián, Julien Fitamant, Cell Tumor BiologyPancreatic CancerMedicinePathologyCancer Biology	2016	316
Rescue of TRAF3-null mice by p100 NF-κB deficiency Jeannie Q. He, Brian Zarnegar, Gagik Oganesyan, The Journal of Experimental Medicine	2006	163
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma Supriya K. Saha, John D. Gordan, Benjamin P. Kleinstiver, Cancer Discovery	2016	158

Page 1